Literature DB >> 23087781

Nanoparticles for Uveal Melanoma Treatment.

Sheng Zhang1, Jun Zhou, Zhibing Hu, Ashwin Nair, Liping Tang.   

Abstract

Chemotherapy is a common treatment for uveal melanoma. Rapid clearance of injected drug from the vitreous, necessitates repeated injections in to the eye. We have investigated the use of hydrogel particles to deliver chemotherapeutic drugs to the uveal melanoma site. Fluorescent dye-labeled nano- and micro-particles were injected intravenously into the animal. Particle accumulation in the uveal tissue was studied. The nanoparticles showed a much higher accumulation in the uveal tissue than the microparticles. The optimal particle size is between 100 and 300 nm. These particles could be decorated with targeting moieties and loaded with chemotherapeutic drugs to achieve sustained release at the cancerous site.

Entities:  

Year:  2008        PMID: 23087781      PMCID: PMC3474326          DOI: 10.1109/NANO.2008.245

Source DB:  PubMed          Journal:  Proc IEEE Conf Nanotechnol        ISSN: 1944-9399


  6 in total

1.  Incidence of ocular melanoma in the general population and in glaucoma patients.

Authors:  C Huerta; L A Rodríguez
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.

Authors:  D Sharma; T P Chelvi; J Kaur; K Chakravorty; T K De; A Maitra; R Ralhan
Journal:  Oncol Res       Date:  1996       Impact factor: 5.574

3.  Fluorescein and indocyanine green videoangiography of choroidal melanomas.

Authors:  L S Atmaca; F Batioğlu; P Atmaca
Journal:  Jpn J Ophthalmol       Date:  1999 Jan-Feb       Impact factor: 2.447

4.  Tissue responses to thermally-responsive hydrogel nanoparticles.

Authors:  Hong Weng; Jun Zhou; Liping Tang; Zhibing Hu
Journal:  J Biomater Sci Polym Ed       Date:  2004       Impact factor: 3.517

Review 5.  Nanoparticles in cancer therapy and diagnosis.

Authors:  Irène Brigger; Catherine Dubernet; Patrick Couvreur
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

6.  Prognostic factors following enucleation of 111 uveal melanomas.

Authors:  K Coleman; J P Baak; P Van Diest; J Mullaney; M Farrell; M Fenton
Journal:  Br J Ophthalmol       Date:  1993-11       Impact factor: 4.638

  6 in total
  2 in total

Review 1.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

2.  NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.

Authors:  Ashwin Nair; Paul Thevenot; Wenjing Hu; Liping Tang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.